Deal Support

M&A Advisory

Buy-side and sell-side M&A advisory for cross-border transactions involving Iranian companies and assets.

Advisory team reviewing documents over Tehran skyline at dusk

Cross-border M&A involving Iran has a narrow pool of advisers who genuinely understand both sides of the table. We act for foreign buyers acquiring Iranian targets, Iranian shareholders selling to international acquirers, and groups carving out non-core Iranian operations. Every mandate is run with a sanctions-screening overlay and a clear path to capital repatriation.

What’s Included

Target Identification

Curated long-list and short-list of acquisition targets in your sector.

  • Sector mapping
  • Ownership analysis
  • Financial filtering
  • Discreet approach
  • Pipeline management

Valuation

DCF, trading-comparables, and precedent-transaction valuations adjusted for Iran risk.

  • DCF model
  • Comparable companies
  • Precedent transactions
  • Country-risk premium
  • Sensitivity analysis

Deal Structuring

Design share vs asset deals, earn-outs, and roll-over equity to bridge price gaps.

  • Share vs asset
  • Earn-out design
  • Deferred consideration
  • Roll-over equity
  • Working-capital target

Negotiation Support

Lead or support negotiations with Iranian shareholders and management teams.

  • Term-sheet drafting
  • SPA negotiation
  • Reps & warranties
  • Indemnity caps
  • Closing conditions

DD Coordination

Manage legal, financial, tax, and commercial DD streams under one project plan.

  • DD project plan
  • Vendor management
  • Findings synthesis
  • Issues list
  • Pre-closing remediation

Closing & Integration

Run the closing mechanics and the first 100 days of integration.

  • Conditions precedent
  • Funds flow
  • Completion accounts
  • Day-1 readiness
  • 100-day plan

How We Engage

1

Mandate

Agree the mandate, fee structure, and exclusivity.

2

Origination

Identify and approach targets or buyers under NDA.

3

Negotiation

Run term-sheet, DD, and SPA negotiations to signing.

4

Closing

Satisfy conditions precedent, exchange funds, and transfer title.

5

Integration

Stand up post-closing governance and the 100-day plan.

Run Your Iran M&A Process

Engage advisers who have closed cross-border Iranian deals end-to-end.

Cross-border Iranian M&A

A narrow market that rewards experienced advisers

Closed cross-border M&A involving Iranian targets requires fluency in three domains at once: Iranian corporate law, international sanctions, and capital repatriation. We run buy-side and sell-side mandates with that overlay built in from the first conversation.

6–12 mths
Typical mandate
USD
Reporting currency
Bilingual
SPA execution
FIPPA
Repatriation route

Origination

Discreet target or buyer identification through our partner network, with first contact handled under NDA and pre-cleared sanctions screening.

Valuation discipline

DCF, trading-comps, and precedent-transaction valuations adjusted for Iran-specific country-risk premia and FX assumptions.

Closing mechanics

Conditions precedent, funds flow, completion accounts, and FIPPA registration all sequenced in one closing plan.

FAQ

Frequently asked questions

Can foreign acquirers actually close on Iranian targets today?+

Yes — non-US, non-sanctioned acquirers close transactions regularly, particularly in petrochemicals, mining, and consumer sectors. We do not advise on transactions that would breach US primary sanctions.

How do you handle escrow when traditional escrow banks are unavailable?+

We use bilateral escrow with a regional bank acceptable to both sides, or a deferred-consideration structure tied to post-closing milestones. The right answer is deal-specific.

Do you co-invest?+

Selectively — only on transactions where partner-level co-investment aligns interests. Standard mandates are pure advisory with a success fee.

How are success fees structured?+

A retainer covering work-product, plus a success fee scaled to enterprise value with a minimum floor. Standard Lehman-formula variants are acceptable on larger deals.